Bedell Frazier Investment Counselling’s iShares Biotechnology ETF IBB Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,719	Closed	-$201K	–	102
2022 Q3	$201K	Sell	1,719 -430	-20%	-$53.4K	0.06%	94
2022 Q2	$253K	Sell	2,149 -183	-8%	-$21.7K	0.08%	72
2022 Q1	$304K	Sell	2,332 -48	-2%	-$6.25K	0.08%	78
2021 Q4	$363K	Sell	2,380 -461	-16%	-$71.4K	0.09%	81
2021 Q3	$459K	Sell	2,841 -8	-0.3%	-$1.35K	0.13%	63
2021 Q2	$466K	Sell	2,849 -49	-2%	-$7.55K	0.12%	68
2021 Q1	$436K	Sell	2,898 -143	-5%	-$22.7K	0.12%	66
2020 Q4	$461K	Buy	3,041 +375	+14%	+$53.6K	0.14%	63
2020 Q3	$361K	Buy	+2,666	New	+$362K	0.13%	61
2017 Q3	–	Sell	-11,871	Closed	-$1.23M	–	43
2017 Q2	$1.23M	Buy	11,871 +1,059	+10%	+$104K	0.45%	36
2017 Q1	$1.06M	Buy	10,812 +1,287	+14%	+$123K	0.4%	34
2016 Q4	$843K	Buy	+9,525	New	+$867K	0.33%	39
2016 Q2	–	Sell	-30,000	Closed	-$876K	–	47
2016 Q1	$876K	Sell	30,000 -900	-3%	-$80.5K	0.45%	30
2015 Q4	$1.16M	Buy	+30,900	New	+$3.35M	0.58%	31
2015 Q3	–	Sell	-35,346	Closed	-$1.46M	–	57
2015 Q2	$1.46M	Buy	35,346 +885	+3%	+$106K	0.58%	39
2015 Q1	$1.36M	Buy	+34,461	New	+$3.8M	0.56%	39

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bedell Frazier Investment Counselling's IBB Position: Q4 2022 in Review

Bedell Frazier Investment Counselling sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 1,719 shares — an estimated $201K sold.

Bedell Frazier Investment Counselling first reported a position in IBB in Q1 2015 and held it in 16 quarters. The position peaked at $1.46M in Q2 2015. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Bedell Frazier Investment Counselling reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
Bedell Frazier Investment Counselling sold 1,719 iShares Biotechnology ETF shares in Q4 2022, an estimated $201K.
Bedell Frazier Investment Counselling first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 16 quarters.
Bedell Frazier Investment Counselling's iShares Biotechnology ETF position peaked at $1.46M in Q2 2015.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Bedell Frazier Investment Counselling's 13F filing for Q4 2022, filed 10 Feb 2023.